Form 8-K - Current report:
SEC Accession No. 0001070081-18-000066
Filing Date
2018-08-24
Accepted
2018-08-24 07:15:13
Documents
7
Period of Report
2018-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 08.24.18 form8-k082418.htm 8-K 85495
2 EXHIBIT 23.1 ex231bdoconsent.htm EX-23.1 3308
3 EXHIBIT 99.1 ex991ptcpressrelease082318.htm EX-99.1 12305
4 EXHIBIT 99.2 ex992agilisriskfactors-exh.htm EX-99.2 72198
5 EXHIBIT 99.3 form8-ka082418xexhibit992.htm EX-99.3 829273
6 EXHIBIT 99.4 ex994proforma.htm EX-99.4 318342
7 ptclogoimagea01.jpg GRAPHIC 6428
  Complete submission text file 0001070081-18-000066.txt   1331315
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 181035842
SIC: 2834 Pharmaceutical Preparations